4 ms·

Yours is an interesting situation. Without public funding, in my opinion you have no moral obligation to provide free (as in beer) access to your software. Inde

by Blahah 14y ago

Yours is an interesting situation. Without public funding, in my opinion you have no moral obligation to provide free (as in beer) access to your software. Indeed, the greater social benefit (if there's a binary choice between nothing being published and there being a paper but no free (as in beer) source code), is gained by you publishing a description of the work. Others can then at least benefit from your theoretical advances. To directly answer your first question: I don't think there are any ethical limits on what you can charge (but there are economic ones). Which outcome is better for overall scientific progress depends entirely on what your software does, how large the need for it is, etc. However, one thing that is almost certainly true is that providing free (all senses) access to the software will maximise the social benefit. So if you can find a model that allows you to profit whilst still doing this, I encourage you to do so (see last point). If I were in your situation I would say the issue of whether or not to publish is economic: publishing a paper about the software will bring it to the attention of the scientific community. That should lead to increased custom for you, provided the software is good and priced appropriately. An example of this is Robert Edgar of http://www.drive5.com http://www.drive5.com. He has written several pieces of software which have really advanced computational biology, especially USEARCH. He makes the 32-bit version available freely, and there's a ~$800 per machine license for the 64-bit version. He also makes some tools available freely. This mixed model seems to have performed very well for him, as he is very widely cited which gets him a high profile and many large bioinformatics institutions buy licenses for his software. Again, whether publishing open access is a good idea depends on which journal you publish in, how many people will benefit from learning of your advances, etc. Since you say all the people who have paid for your software are for-profits, you could consider an unrestricted academic license with a paid commercial license (similar to all the baseclear products: http://www.baseclear.com/landingpages/basetools-a-wide-range-of-bioinformatics-solutions/sspacev12/ http://www.baseclear.com/landingpages/basetools-a-wide-range...).

dalke 14y ago
"I don't think there are any ethical limits on what you can charge" I think you can see that some others hold a different viewpoint from you and me. I've heard people say that the ability to review the software is essential for science and that the software must, in all cases, be available for trivial if not no cost, in order to allow that review. (I think this view doesn't have a moral justification.) "the issue of whether or not to publish is economic" Absolutely. It's advertising. It's then a question for me to decide how to maximize my profits AND maximize improvements to the field. (Only somewhat apropos, I always loved reading the PNAS blub for each article: "The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.") Getting back to the topic, suppose that a group uses 64-bit USEARCH to do research. You wrote "I'm saying that publishing the source code so that others can run and modify it is the crucial thing." However, that group is unable to provide the source code used to do their analysis. ("Licensee will not allow copies of the Software to be made or used by others", says the 32-bit license.) If publishing the source code is crucial, then this secondary group, which uses the algorithm, is obligated to publish the software they used, no? Or does that obligation only apply to the primary developer of the algorithm? If the primary developer never publishes the source code, then should all secondary users be prohibited from using it in order to develop new science? Does that prohibition extend to using Excel? Oracle? Built-in software in sequencing hardware? I don't see an obvious bright-line demarcation. As for "unrestricted academic license", I disagree with some of the distinction between academic license/commercial license. There are academic labs with a lot more money than I have. The group I was in, in the 1990s, had a NeXT or IRIX box on each student's desk, for example. There are also academic labs which act as a front, of sorts, for a professor's commercial interests. Also, the software I'm working on makes things fast - some 40x more than what people would do on their own. Any group can make the time/money tradeoff, and an academic group may easily have more money than time. I've decided on a different view. Anyone can get access to the older versions, at no cost and under a BSD license. The newer versions are available to anyone, for a fee, and under the BSD license. I'm not dependent on this product for revenue, so it's a test to see how successful this business model might be.

by Blahah 14y ago

dalke 14y ago

"I don't think there are any ethical limits on what you can charge" I think you can see that some others hold a different viewpoint from you and me. I've heard people say that the ability to review the software is essential for science and that the software must, in all cases, be available for trivial if not no cost, in order to allow that review. (I think this view doesn't have a moral justification.) "the issue of whether or not to publish is economic" Absolutely. It's advertising. It's then a question for me to decide how to maximize my profits AND maximize improvements to the field. (Only somewhat apropos, I always loved reading the PNAS blub for each article: "The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.") Getting back to the topic, suppose that a group uses 64-bit USEARCH to do research. You wrote "I'm saying that publishing the source code so that others can run and modify it is the crucial thing." However, that group is unable to provide the source code used to do their analysis. ("Licensee will not allow copies of the Software to be made or used by others", says the 32-bit license.) If publishing the source code is crucial, then this secondary group, which uses the algorithm, is obligated to publish the software they used, no? Or does that obligation only apply to the primary developer of the algorithm? If the primary developer never publishes the source code, then should all secondary users be prohibited from using it in order to develop new science? Does that prohibition extend to using Excel? Oracle? Built-in software in sequencing hardware? I don't see an obvious bright-line demarcation. As for "unrestricted academic license", I disagree with some of the distinction between academic license/commercial license. There are academic labs with a lot more money than I have. The group I was in, in the 1990s, had a NeXT or IRIX box on each student's desk, for example. There are also academic labs which act as a front, of sorts, for a professor's commercial interests. Also, the software I'm working on makes things fast - some 40x more than what people would do on their own. Any group can make the time/money tradeoff, and an academic group may easily have more money than time. I've decided on a different view. Anyone can get access to the older versions, at no cost and under a BSD license. The newer versions are available to anyone, for a fee, and under the BSD license. I'm not dependent on this product for revenue, so it's a test to see how successful this business model might be.